Abstract
Light-chain (AL) cardiac amyloidosis can be treated with cardiac transplantation (HT) followed by high dose melphalan chemotherapy and autologous stem cell transplant. We hypothesized that chemotherapy (CTX) prior to HT targeting clonal plasma cell light chain production may lead to improved
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
